Data sheet

Benchling for gene therapy and editing R&D

Gene therapy and gene editing technologies encompass a wide range of products, including plasmid DNA, viral vectors, CRISPR, ZFNs, TALENs, and siRNAs. These products have been of significant research interest, especially with the recent approval of breakthrough therapies like Luxturna. However, several hurdles persist for companies seeking to develop these novel therapies.
This data sheet discusses:
  • The complexities present in gene therapy research and development 

  • Why current solutions fail to meet these needs

  • How Benchling’s capabilities can uniquely address these challenges 

Companies using Benchling

View data sheet

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image